Teva Pharmaceutical Industries Limited (TLV:TEVA)

TLV:TEVA Revenue

In the year 2025, Teva Pharmaceutical Industries had annual revenue of $17.26B USD with 4.32% growth. Teva Pharmaceutical Industries had revenue of $4.71B in the quarter ending December 31, 2025, with 11.40% growth.

• Revenue: $17.26B
• Revenue Growth: +4.32%
• P/S Ratio: 1.97
• Revenue / Employee: $525.49K
• Employees: 32,842
• Market Cap: 108.44B ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.26B	714.00M	4.32%
Dec 31, 2024	16.54B	698.00M	4.40%
Dec 31, 2023	15.85B	921.00M	6.17%
Dec 31, 2022	14.93B	-953.00M	-6.00%
Dec 31, 2021	15.88B	-781.00M	-4.69%
Dec 31, 2020	16.66B	-228.00M	-1.35%
Dec 31, 2019	16.89B	-1.38B	-7.57%
Dec 31, 2018	18.27B	-3.58B	-16.39%
Dec 31, 2017	21.85B	-50.00M	-0.23%
Dec 31, 2016	21.90B	2.25B	11.45%
Dec 31, 2015	19.65B	-620.00M	-3.06%
Dec 31, 2014	20.27B	-42.00M	-0.21%
Dec 31, 2013	20.31B	-3.00M	-0.01%
Dec 31, 2012	20.32B	2.01B	10.95%
Dec 31, 2011	18.31B	-	-